Ads
related to: how to identify blood cancer markers- Identifying Patients
Discover Patient Identification &
IHC Info. Will You Take Action?
- Dosing & Administration
Healthcare Professionals: See How
Your Patients May Receive Treatment
- Mechanism Of Action
MOA For A Therapy In Multiple
Metastatic Solid Tumor Types.
- Official Physician Site
Visit Site For A Treatment
Option For Metastatic Solid Tumors.
- Access Data & Results
View Data To See If A Treatment For
Metastatic Solid Tumors May Help.
- Request A Contact
Complete A Brief Form To Receive
Updates For A Treatment Option.
- Identifying Patients
Search results
Results From The WOW.Com Content Network
A tumor marker is a biomarker that can be used to ... these are either high-molecular weight mucins or blood group antigens. ... Tumor markers can detect reoccurring ...
A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule." [18] In cancer research and medicine, biomarkers are used in three primary ways: [19] To help diagnose conditions, as in the case of identifying early stage cancers (diagnostic)
It is necessary to distinguish between disease-related and drug-related biomarkers.Disease-related biomarkers give an indication of the probable effect of treatment on patient (risk indicator or predictive biomarkers), if a disease already exists (diagnostic biomarker), or how such a disease may develop in an individual case regardless of the type of treatment (prognostic biomarker).
Biomarker discovery is a medical term describing the process by which biomarkers are discovered. Many commonly used blood tests in medicine are biomarkers. There is interest in biomarker discovery on the part of the pharmaceutical industry; blood-test or other biomarkers could serve as intermediate markers of disease in clinical trials, and as possible drug targets.
In biomedical contexts, a biomarker, or biological marker, is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated using blood, urine, or soft tissues [1] to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. [2]
Tumor antigen is an antigenic substance produced in tumor cells, i.e., it triggers an immune response in the host. Tumor antigens are useful tumor markers in identifying tumor cells with diagnostic tests and are potential candidates for use in cancer therapy. The field of cancer immunology studies such topics.